Press Releases
Stay abreast of the latest developments in Umicore Precious Metals Chemistry through our press releases and news updates.
Umicore Argentina further improves its quality systems after successful FDA audit
Umicore Argentina plant, which produces a series of anti-cancer active pharmaceutical ingredients, was successfully audited for the second time by the US Food and Drug Administration (FDA) in May 2018.
Umicore expands cross coupling technology portfolio with Buchwald precatalysts
Umicore's business unit Precious Metals Chemistry, is proud to announce that it is expanding its existing cross coupling catalyst portfolio with Buchwald precatalysts after it licensed this technology from the Massachusetts Institute of Technology…
Umicore succeeded second Food and Drug Administration audit at its Argentinean manufacturing site
Umicore’s Active Pharmaceutical Ingredients facility in Pilar, Buenos Aires, successfully passed its second cGMP (current Good Manufacturing Practice) audit by the US Food and Drug Administration (FDA) in May 2018. The Auditor acknowledged that…
Umicore to acquire Materia’s Metathesis catalyst business
Umicore announced today that it has reached an agreement to acquire Materia's metathesis catalyst business for an enterprise value of USD million 27. Materia is a leader in metathesis with its unique proprietary technology developed by 2005…
Umicore Hanau passed the TfS (Together for Sustainability) audit program
We are proud to announce the successfully audit of Umicore’s facility in Hanau (Germany) by the Together for Sustainability (TfS) initiative. This confirms and reinforces Umicore’s policy and commitment to sustainability.
Umicore’s Argentinian facility for anticancer APIs passes new European GMP audit
Umicore’s API (Active Pharmaceutical Ingredients) facility in Pilar, Buenos Aires, successfully underwent a European GMP (Good Manufacturing Practice) inspection by the German Health and Medicine Authority. The success of this new audit confirms…